{
  "meta": {
    "title": "Ischemic_Stroke",
    "url": "https://brainandscalpel.vercel.app/ischemic-stroke-3d9883fc.html",
    "scrapedAt": "2025-11-29T18:25:10.659Z"
  },
  "questions": [
    {
      "id": 19855,
      "choices": [
        {
          "id": 79381,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperdense middle cerebral artery (MCA) sign </span></span></p>"
        },
        {
          "id": 79382,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stripe sign </span></span></p>"
        },
        {
          "id": 79383,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radial band sign </span></span></p>"
        },
        {
          "id": 79384,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eye-of-the-tiger sign</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old male with uncontrolled hypertension presents with sudden left-sided weakness and difficulty speaking. He has right-sided hemiparesis and aphasia. An urgent non-contrast head CT scan is shown. What is this finding indicative of?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-111854.jpg\" style=\"height:284px; width:300px\" /></span></span></p>",
      "unique_key": "Q3707677",
      "question_audio": null,
      "question_video": null,
      "map_id": 19830,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A) Hyperdense middle cerebral artery (MCA) sign</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The hyperdense MCA sign on non-contrast CT is a direct visualization of a thrombus within the MCA, indicative of an acute ischemic stroke.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Stripe sign:</strong> Thin line of contrast enhancement within a hyperdense vessel, indicating partial occlusion. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Radial band sign:</strong> Linear bands of differing density in white matter, seen in multiple sclerosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;<strong>Option D. Eye-of-the-tiger sign:</strong> Hypointense globus pallidus with central hyperintensity on MRI, seen in PKAN.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize the hyperdense MCA sign on NCCT as an early indicator of acute ischemic stroke.</span></span></p>",
      "correct_choice_id": 79381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19856,
      "choices": [
        {
          "id": 79385,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salvageable ischemic area </span></span></p>"
        },
        {
          "id": 79386,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Core infarct area </span></span></p>"
        },
        {
          "id": 79387,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Older infarct </span></span></p>"
        },
        {
          "id": 79388,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ischemic penumbra</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 55-year-old female with atrial fibrillation presents with right-sided weakness and slurred speech. NCCT head is normal, DWI is done. What does this hyperintense area represent?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-111907.jpg\" style=\"height:282px; width:300px\" /></span></span></p>",
      "unique_key": "Q9547758",
      "question_audio": null,
      "question_video": null,
      "map_id": 19831,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>B) Core infarct area</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hyperintensity on DWI indicates restricted diffusion, which is characteristic of the core infarct area where irreversible tissue damage has occurred.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Salvageable ischemic area:</strong> Salvageable ischemic area (penumbra) is not hyperintense on DWI. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Older infarcts area:</strong> Older infarcts may appear hypointense on DWI. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Ischemic penumbra:</strong> Ischemic penumbra is the area surrounding the core, potentially salvageable with timely intervention, but not hyperintense on DWI.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand that hyperintensity on DWI indicates the core of an acute ischemic stroke, where tissue damage is irreversible.</span></span></p>",
      "correct_choice_id": 79386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19857,
      "choices": [
        {
          "id": 79389,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Left facial droop </span></span></p>"
        },
        {
          "id": 79390,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Slurred speech </span></span></p>"
        },
        {
          "id": 79391,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Left arm weakness </span></span></p>"
        },
        {
          "id": 79392,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old male presents with sudden left-sided weakness and slurred speech. He has left facial droop, left arm and leg weakness, and slurred speech. He is alert and oriented, follows commands, and has no visual field deficits. Which of the following findings would contribute to his NIHSS score?</span></span></p>",
      "unique_key": "Q4320954",
      "question_audio": null,
      "question_video": null,
      "map_id": 19832,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>D) All of the above</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The NIHSS is a comprehensive stroke scale. All the mentioned findings &ndash; facial droop, slurred speech, and arm weakness &ndash; are assessed under different items of the NIHSS and would contribute to the overall score.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize that the NIHSS encompasses various neurological deficits, including motor function, language, and cranial nerve function, to provide a comprehensive assessment of stroke severity.</span></span></p>",
      "correct_choice_id": 79392,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19858,
      "choices": [
        {
          "id": 79393,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous tissue plasminogen activator (tPA) </span></span></p>"
        },
        {
          "id": 79394,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate anticoagulation with warfarin </span></span></p>"
        },
        {
          "id": 79395,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral aspirin therapy </span></span></p>"
        },
        {
          "id": 79396,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endovascular thrombectomy without intravenous tPA</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old female with atrial fibrillation presents with sudden right-sided weakness and aphasia. Her NIHSS score is 14, and non-contrast head CT shows no hemorrhage. What is the most appropriate management based on current guidelines?</span></span></p>",
      "unique_key": "Q9243424",
      "question_audio": null,
      "question_video": null,
      "map_id": 19833,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A) Intravenous tissue plasminogen activator (tPA)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Given her presentation within the 4.5-hour window, absence of hemorrhage on CT, and significant neurological deficit (NIHSS 14), tPA is the most appropriate initial treatment for acute ischemic stroke.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Immediate anticoagulation with warfarin:</strong> Warfarin is for long-term prevention, not acute treatment. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Oral aspirin therapy:</strong> &nbsp;Aspirin is used after the acute phase for secondary prevention. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Endovascular thrombectomy without intravenous tPA: </strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Thrombectomy may be considered later if tPA fails or is contraindicated.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand that IV tPA is the first-line treatment for eligible patients with acute ischemic stroke within the appropriate time window.</span></span></p>",
      "correct_choice_id": 79393,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19859,
      "choices": [
        {
          "id": 79397,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT Angiogram </span></span></p>"
        },
        {
          "id": 79398,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI brain </span></span></p>"
        },
        {
          "id": 79399,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous tPA</span></span></p>"
        },
        {
          "id": 79400,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endovascular thrombectomy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 55-year-old male with hypertension has sudden left-sided weakness and aphasia, last seen well 6 hours ago. His NIHSS score is 12, and NCCT head shows no hemorrhage. What is the most appropriate next step in management?</span></span></p>",
      "unique_key": "Q8057104",
      "question_audio": null,
      "question_video": null,
      "map_id": 19834,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A) CT Angiogram</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Since the patient is outside the tPA window, the next step is a CT angiogram to assess for large vessel occlusion (LVO), which would determine eligibility for endovascular thrombectomy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong> </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. MRI brain:</strong>&nbsp; MRI is more detailed but takes longer in the acute setting. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Intravenous tPA:</strong>&nbsp; tPA is contraindicated beyond 4.5 hours from symptom onset.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Endovascular thrombectomy:&nbsp;</strong>Thrombectomy cannot be performed without confirming LVO.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize that CT angiogram is the next step in stroke management after the tPA window to evaluate for LVO and determine eligibility for thrombectomy.</span></span></p>",
      "correct_choice_id": 79397,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19860,
      "choices": [
        {
          "id": 79401,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT perfusion </span></span></p>"
        },
        {
          "id": 79402,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeat NCCT </span></span></p>"
        },
        {
          "id": 79403,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MR angiogram </span></span></p>"
        },
        {
          "id": 79404,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lumbar puncture</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old female with diabetes presents with sudden right-sided weakness and difficulty speaking 8 hours ago. NIHSS is 15, NCCT shows no hemorrhage, and CTA reveals an LVO in the left MCA. What is the most appropriate next step?</span></span></p>",
      "unique_key": "Q2520007",
      "question_audio": null,
      "question_video": null,
      "map_id": 19835,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A) CT perfusion</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Given the large vessel occlusion and time since onset, CT perfusion is crucial to assess the extent of ischemic penumbra (salvageable tissue) and determine eligibility for endovascular thrombectomy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong> </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Repeat NCCT: &nbsp;</strong>Is unnecessary as there&#39;s no suspicion of new hemorrhage. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. MR Angiogram:</strong> Confirms LVO but doesn&#39;t provide tissue viability information. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Lumbar puncture:</strong> &nbsp;Is not indicated in this scenario.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understand the role of CT perfusion in assessing tissue viability and guiding endovascular therapy decisions in stroke.</span></span></p>",
      "correct_choice_id": 79401,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19861,
      "choices": [
        {
          "id": 79405,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stroke onset 90 minutes ago </span></span></p>"
        },
        {
          "id": 79406,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of atrial fibrillation </span></span></p>"
        },
        {
          "id": 79407,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recent gastrointestinal bleeding </span></span></p>"
        },
        {
          "id": 79408,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood glucose level of 140 mg/dL</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old male with atrial fibrillation and recent GI bleeding presents with sudden left-sided weakness and slurred speech 90 minutes ago. His NIHSS score is 10, and NCCT shows no hemorrhage. Which of the following is a contraindication to IV tPA?</span></span></p>",
      "unique_key": "Q6583529",
      "question_audio": null,
      "question_video": null,
      "map_id": 19836,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>C) Recent gastrointestinal bleeding</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recent GI bleeding is a contraindication to tPA due to the increased risk of hemorrhagic complications.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Stroke onset 90 minutes ago</strong>: Onset of 90 minutes is within the tPA window. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. History of atrial fibrillation:</strong> Atrial fibrillation is a risk factor for stroke, not a contraindication to tPA. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Blood glucose level of 140 mg/dL:</strong> Blood glucose of 140 mg/dL is within the acceptable range for tPA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Be aware of the contraindications to tPA, including recent bleeding, to avoid serious complications.</span></span></p>",
      "correct_choice_id": 79407,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19862,
      "choices": [
        {
          "id": 79409,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.25 mg/kg as a single bolus</span></span></p>"
        },
        {
          "id": 79410,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.25 mg/kg as 10% bolus followed by 90% infusion</span></span></p>"
        },
        {
          "id": 79411,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.9 mg/kg as a single bolus</span></span></p>"
        },
        {
          "id": 79412,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.9 mg/kg infused over 60 minutes</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the appropriate dosing of tenecteplase for a 70kg patient with acute ischemic stroke?</span></span></p>",
      "unique_key": "Q5508152",
      "question_audio": null,
      "question_video": null,
      "map_id": 19837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) 0.25 mg/kg as a single bolus</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tenecteplase is administered as a single bolus, unlike alteplase. The correct dose is 0.25 mg/kg (not exceeding 25 mg total).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. 0.25 mg/kg as 10% bolus followed by 90% infusion:</strong> This is the dosing for alteplase. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. 0.9 mg/kg as a single bolus:</strong> This is the maximum dose for alteplase. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. 0.9 mg/kg infused over 60 minutes:</strong> Tenecteplase is not infused over time.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Know the correct dosing and administration of tenecteplase, a thrombolytic agent used in acute stroke.</span></span></p>",
      "correct_choice_id": 79409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19863,
      "choices": [
        {
          "id": 79413,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of 52 years </span></span></p>"
        },
        {
          "id": 79414,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NIHSS score of 18 </span></span></p>"
        },
        {
          "id": 79415,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of extensive early ischemic changes (ASPECTS 5)</span></span></p>"
        },
        {
          "id": 79416,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CTA showing right ICA occlusion</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old woman presents with acute left hemiparesis and facial droop 3 hours ago. Her NIHSS score is 18, and NCCT shows early ischemic changes (ASPECTS score of 5). CTA reveals a right ICA occlusion. Which factor would make her ineligible for endovascular therapy (thrombectomy)?</span></span></p>",
      "unique_key": "Q4274392",
      "question_audio": null,
      "question_video": null,
      "map_id": 19838,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Presence of extensive early ischemic changes (ASPECTS 5)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A low ASPECTS score indicates significant early ischemic changes, making the patient ineligible for thrombectomy due to high risk of hemorrhagic transformation and poor outcome.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Age of 52 years</strong>: Age is not an absolute contraindication. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. NIHSS score of 18:</strong> &nbsp;High NIHSS score indicates severity but doesn&#39;t exclude thrombectomy. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. CTA showing right ICA occlusion:</strong> ICA occlusion is an indication for thrombectomy if other criteria are met.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understand that the presence of extensive early ischemic changes, reflected by a low ASPECTS score, is a contraindication for endovascular therapy.</span></span></p>",
      "correct_choice_id": 79415,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19864,
      "choices": [
        {
          "id": 79417,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start IV labetalol to reduce SBP &lt;185 mmHg and DBP &lt;110 mmHg. </span></span></p>"
        },
        {
          "id": 79418,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer oral antihypertensives to gradually reduce BP over 24 hours. </span></span></p>"
        },
        {
          "id": 79419,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Withhold antihypertensive treatment unless SBP exceeds 220 mmHg. </span></span></p>"
        },
        {
          "id": 79420,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediately start IV tPA.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man with hypertension presents with sudden left-sided weakness and difficulty speaking. His blood pressure is 200/124 mmHg. His NIHSS score is 14, and NCCT shows no hemorrhage. What is the most appropriate management of his blood pressure before administering tPA?</span></span></p>",
      "unique_key": "Q5700754",
      "question_audio": null,
      "question_video": null,
      "map_id": 19839,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) Start IV labetalol to reduce SBP &lt;185 mmHg and DBP &lt;110 mmHg.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Before administering tPA, blood pressure should be lowered to below 185/110 mmHg to reduce the risk of hemorrhagic transformation. IV labetalol is a rapid-acting agent suitable for this purpose.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Administer oral antihypertensives to gradually reduce BP over 24 hours:</strong> &nbsp;Oral antihypertensives are too slow for this acute setting. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Withhold antihypertensive treatment unless SBP exceeds 220 mmHg: </strong>Withholding treatment with such high BP is inappropriate. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Immediately start IV tPA:</strong> &nbsp;tPA should not be given before achieving target BP.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the importance of blood pressure control before administering tPA in acute ischemic stroke.</span></span></p>",
      "correct_choice_id": 79417,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19865,
      "choices": [
        {
          "id": 79421,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">70-110 mg/dL </span></span></p>"
        },
        {
          "id": 79422,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">110-150 mg/dL </span></span></p>"
        },
        {
          "id": 79423,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">140-180 mg/dL </span></span></p>"
        },
        {
          "id": 79424,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">180-220 mg/dL</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the recommended target range for blood glucose in acute ischemic stroke management?</span></span></p>",
      "unique_key": "Q4653344",
      "question_audio": null,
      "question_video": null,
      "map_id": 19840,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) 140-180 mg/dL</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This moderate range avoids the risks of both hypoglycemia and hyperglycemia, which can worsen outcomes in acute stroke.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. 70-110 mg/dL:</strong> This range is too narrow and risks hypoglycemia. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. 110-150 mg/dL:</strong> &nbsp;This range is on the lower end and may also risk hypoglycemia. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. 180-220 mg/dL:</strong> This range is too high and may exacerbate ischemic injury.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Know the target blood glucose range for acute ischemic stroke management to optimize outcomes.</span></span></p>",
      "correct_choice_id": 79423,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19866,
      "choices": [
        {
          "id": 79425,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous mannitol </span></span></p>"
        },
        {
          "id": 79426,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevate the head of the bed to 30 degrees </span></span></p>"
        },
        {
          "id": 79427,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate decompressive craniectomy </span></span></p>"
        },
        {
          "id": 79428,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High-dose corticosteroids</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old man with hypertension, diabetes, and hyperlipidemia presents with sudden expressive aphasia, right facial droop, and right hemiparesis. He receives IV tPA, but 24 hours later his condition worsens, and repeat CT shows significant cerebral edema with midline shift. What is the most appropriate next step?</span></span></p>",
      "unique_key": "Q4143636",
      "question_audio": null,
      "question_video": null,
      "map_id": 19841,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong><strong> A) Intravenous mannitol</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mannitol is an osmotic diuretic used to reduce cerebral edema and lower intracranial pressure, which is the primary concern in this patient with worsening neurological status and midline shift.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Elevate the head of the bed to 30 degrees:</strong> &nbsp;Head elevation can help, but it&#39;s unlikely to be enough in this severe case. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Immediate decompressive craniectomy:</strong> Decompressive craniectomy is a last resort if medical management fails.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. High-dose corticosteroids:</strong> &nbsp;Corticosteroids are not recommended for cerebral edema in ischemic stroke.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understand the role of mannitol in managing increased intracranial pressure due to cerebral edema in stroke.</span></span></p>",
      "correct_choice_id": 79425,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19868,
      "choices": [
        {
          "id": 79433,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP of 170/100 mmHg</span></span></p>"
        },
        {
          "id": 79434,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of 63 years </span></span></p>"
        },
        {
          "id": 79435,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Difficulty in chewing</span></span></p>"
        },
        {
          "id": 79436,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of hyperlipidemia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 63-year-old man with a history of hypertension, hyperlipidemia, and smoking presents with sudden confusion and right-sided weakness. He also has difficulty chewing. Which factor most likely increases his risk of dysphagia?</span></span></p>",
      "unique_key": "Q3823761",
      "question_audio": null,
      "question_video": null,
      "map_id": 19843,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Difficulty in chewing</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Difficulty chewing is a direct sign of impaired oral motor function, which is crucial for the initial phases of swallowing. This suggests a potential neurological deficit affecting the swallowing mechanism, making dysphagia more likely.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. BP of 170/100 mmHg:</strong> High blood pressure is a risk factor for stroke, but not directly for dysphagia. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Age of 63 years:</strong> While dysphagia is more common in older individuals, difficulty chewing is a more specific indicator in this case. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. History of hyperlipidemia:</strong> &nbsp;Hyperlipidemia is a risk factor for stroke but doesn&#39;t directly affect swallowing.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize that difficulty chewing in an acute stroke patient indicates a higher risk of dysphagia, requiring further assessment and intervention to prevent complications like aspiration pneumonia.</span></span></p>",
      "correct_choice_id": 79435,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19867,
      "choices": [
        {
          "id": 79429,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue warfarin with INR 2-3 </span></span></p>"
        },
        {
          "id": 79430,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer low-molecular-weight heparin (LMWH) </span></span></p>"
        },
        {
          "id": 79431,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start unfractionated heparin (UFH) infusion </span></span></p>"
        },
        {
          "id": 79432,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No additional prophylaxis is needed</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old woman with atrial fibrillation and hypertension on warfarin presents with right-sided weakness, slurred speech, and left MCA stroke. Her INR is 2.6. She is immobile due to hemiplegia. What is the most appropriate VTE prophylaxis?</span></span></p>",
      "unique_key": "Q7769656",
      "question_audio": null,
      "question_video": null,
      "map_id": 19842,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>B) Administer low-molecular-weight heparin (LMWH)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LMWH is the preferred VTE prophylaxis in acute stroke patients due to its efficacy and lower bleeding risk compared to UFH. It can be safely used even if the patient is on warfarin, as long as the INR is not supratherapeutic.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Continue warfarin with INR 2-3:</strong>&nbsp; Continuing warfarin may not provide adequate VTE prophylaxis in the acute setting. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Start unfractionated heparin (UFH) infusion:</strong>&nbsp; UFH requires more frequent monitoring and adjustments. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. No additional prophylaxis is needed: </strong>&nbsp;Immobile stroke patients are at high risk for VTE and require prophylaxis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understand the importance of VTE prophylaxis in immobile stroke patients, and that LMWH is generally preferred over UFH.</span></span></p>",
      "correct_choice_id": 79430,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54198,
      "choices": [
        {
          "id": 216261,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue medical management with aspirin and statin therapy. </span></span></p>"
        },
        {
          "id": 216262,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schedule a carotid endarterectomy (CEA). </span></span></p>"
        },
        {
          "id": 216263,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate anticoagulation with warfarin. </span></span></p>"
        },
        {
          "id": 216264,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform carotid artery stenting (CAS).</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old man with hypertension, hyperlipidemia, and a 30-pack-year smoking history presents with right-sided weakness and aphasia. CT shows a left MCA stroke. Carotid duplex shows 80% stenosis of the left ICA. He is started on aspirin and a high-intensity statin. What is the most appropriate next step?</span></span></p>",
      "unique_key": "Q2104752",
      "question_audio": null,
      "question_video": null,
      "map_id": 25692,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>B) Schedule a carotid endarterectomy (CEA)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Given the patient&#39;s recent ischemic stroke and significant (80%) stenosis of the ipsilateral ICA, CEA is recommended to reduce the risk of future strokes. CEA is often preferred over CAS in patients who are suitable surgical candidates.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Continue medical management with aspirin and statin therapy:</strong> Medical management alone is not sufficient for high-grade stenosis with recent symptoms.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Initiate anticoagulation with warfarin:</strong> &nbsp;Anticoagulation is primarily for cardioembolic strokes, not carotid stenosis. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Perform carotid artery stenting (CAS): </strong>&nbsp;CAS is an alternative for high-risk surgical patients, but CEA is generally preferred.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In symptomatic patients with high-grade carotid stenosis, CEA is recommended to prevent future strokes.</span></span></p>",
      "correct_choice_id": 216262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54199,
      "choices": [
        {
          "id": 216265,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue warfarin with more frequent INR monitoring. </span></span></p>"
        },
        {
          "id": 216266,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to a direct oral anticoagulant (DOAC). </span></span></p>"
        },
        {
          "id": 216267,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate aspirin therapy. </span></span></p>"
        },
        {
          "id": 216268,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start dual antiplatelet therapy with aspirin and clopidogrel.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 75-year-old woman with atrial fibrillation and hypertension on warfarin presents with left-sided weakness, slurred speech, and a right MCA stroke. Her INR is subtherapeutic (1.5). What is the most appropriate anticoagulation strategy going forward?</span></span></p>",
      "unique_key": "Q4083829",
      "question_audio": null,
      "question_video": null,
      "map_id": 25693,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>B) Switch to a direct oral anticoagulant (DOAC)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">DOACs are preferred over warfarin for stroke prevention in atrial fibrillation due to their more predictable anticoagulant effect and lower bleeding risk. Switching to a DOAC is especially appropriate after a stroke while on subtherapeutic warfarin.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Continue warfarin with more frequent INR monitoring:</strong> &nbsp;Frequent INR monitoring may not guarantee optimal warfarin control. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Initiate aspirin therapy:</strong> &nbsp;Aspirin is not sufficient for stroke prevention in atrial fibrillation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Start dual antiplatelet therapy with aspirin and clopidogrel: </strong>&nbsp;Dual antiplatelet therapy is not routinely recommended for atrial fibrillation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the advantages of DOACs over warfarin in stroke prevention for atrial fibrillation, especially in cases of subtherapeutic INR.</span></span></p>",
      "correct_choice_id": 216266,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54200,
      "choices": [
        {
          "id": 216269,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute ischemic stroke </span></span></p>"
        },
        {
          "id": 216270,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dissociative disorder </span></span></p>"
        },
        {
          "id": 216271,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transient ischemic attack (TIA) </span></span></p>"
        },
        {
          "id": 216272,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man experiences sudden right-sided weakness and difficulty speaking that completely resolved within 30 minutes. He has a history of hypertension, hyperlipidemia and smoking. Neurological exam and head CT are normal. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8387289",
      "question_audio": null,
      "question_video": null,
      "map_id": 25694,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Transient ischemic attack (TIA)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">TIAs are characterized by transient neurological deficits caused by temporary interruption of blood flow to the brain. Symptoms typically last less than one hour and resolve completely, as seen in this case.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong> </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Acute ischemic stroke:</strong> &nbsp;Ischemic stroke would have persistent neurological deficits. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Dissociative disorder:</strong>&nbsp; Dissociative disorders are psychological in nature and don&#39;t typically mimic stroke symptoms. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>None of the above: </strong>This presentation fits the definition of TIA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand that TIAs are warning signs of potential stroke and require prompt evaluation and management.</span></span></p>",
      "correct_choice_id": 216271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54201,
      "choices": [
        {
          "id": 216273,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 </span></span></p>"
        },
        {
          "id": 216274,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 </span></span></p>"
        },
        {
          "id": 216275,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 </span></span></p>"
        },
        {
          "id": 216276,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman with hypertension and diabetes has a TIA with speech difficulty and right-sided weakness lasting 20 minutes. What is her ABCD2 score?</span></span></p>",
      "unique_key": "Q8592471",
      "question_audio": null,
      "question_video": null,
      "map_id": 25695,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>C) 5</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Age (0 points for &lt;60 years old)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Blood pressure (1 point for &ge;140/90 mmHg)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Clinical features (2 points for unilateral weakness)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Duration (1 point for 10-59 minutes)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Diabetes (1 point)</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Total = 5</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Know how to calculate the ABCD2 score, a clinical tool to assess stroke risk after a TIA.</span></span></p>",
      "correct_choice_id": 216275,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54202,
      "choices": [
        {
          "id": 216277,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior limb of internal capsule</span></span></p>"
        },
        {
          "id": 216278,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventral thalamus</span></span></p>"
        },
        {
          "id": 216279,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genu of internal capsule</span></span></p>"
        },
        {
          "id": 216280,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventral pons</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old woman with hypertension has acute dysarthria. MRI reveals a lacunar stroke. Which part of the brain is most likely affected?</span></span></p>",
      "unique_key": "Q4551111",
      "question_audio": null,
      "question_video": null,
      "map_id": 25696,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>C) Genu of internal capsule</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dysarthria (slurred speech) in the context of a lacunar stroke often localizes to the genu of the internal capsule, which contains fibers of the corticobulbar tract responsible for speech articulation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Posterior limb:</strong> Affects contralateral limbs, causing hemiparesis. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Ventral thalamus: </strong>Affects sensory and motor relay, causing sensory disturbances or movement disorders. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Ventral pons:</strong> Could cause dysarthria but typically also involves hemiparesis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Understand the anatomy of lacunar strokes and how different locations can lead to specific neurological deficits.</span></span></p>",
      "correct_choice_id": 216279,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54203,
      "choices": [
        {
          "id": 216281,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aneurysmal dilation of the anterior communicating artery </span></span></p>"
        },
        {
          "id": 216282,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occlusion of the left middle cerebral artery (MCA) </span></span></p>"
        },
        {
          "id": 216283,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dissection of the right internal carotid artery </span></span></p>"
        },
        {
          "id": 216284,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arteriovenous malformation in the occipital lobe</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with hypertension presents with sudden severe headache, right-sided partial vision loss, and difficulty speaking. He has right homonymous hemianopia and slurred speech. CT head is normal. What is the MRA most likely to show?</span></span></p>",
      "unique_key": "Q3207888",
      "question_audio": null,
      "question_video": null,
      "map_id": 25697,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>B) Occlusion of the left middle cerebral artery (MCA)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The sudden onset of headache, aphasia, and homonymous hemianopia suggests an ischemic stroke in the left MCA territory. MRA would likely show the occlusion.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Aneurysmal dilation of the anterior communicating artery: </strong>Aneurysm would more likely present with subarachnoid hemorrhage. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Dissection of the right internal carotid artery:</strong> Carotid dissection could cause stroke, but the symptoms are more suggestive of MCA territory. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Arteriovenous malformation in the occipital lobe:</strong> &nbsp;AVM would be visible on CT, and occipital AVM would likely cause only visual symptoms.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the presentation of MCA stroke and the role of MRA in confirming the diagnosis.</span></span></p>",
      "correct_choice_id": 216282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54204,
      "choices": [
        {
          "id": 216285,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple hyperintense lesions in white matter on T2-weighted images </span></span></p>"
        },
        {
          "id": 216286,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute infarction in the MCA territory </span></span></p>"
        },
        {
          "id": 216287,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meningeal enhancement </span></span></p>"
        },
        {
          "id": 216288,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal brain parenchyma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman with SLE and chronic kidney disease presents with sudden severe headache, blurred vision, confusion, and hypertension. Fundoscopy shows bilateral papilledema. MRI is most likely to show which of the following?</span></span></p>",
      "unique_key": "Q5307009",
      "question_audio": null,
      "question_video": null,
      "map_id": 25698,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A) Multiple hyperintense lesions in white matter on T2-weighted images</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This presentation is suggestive of posterior reversible encephalopathy syndrome (PRES), often associated with hypertension and renal disease. MRI typically shows hyperintense white matter lesions on T2-weighted images.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Acute infarction in the MCA territory:</strong> MCA infarction would present with focal neurological deficits. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Meningeal enhancement:</strong> Meningeal enhancement suggests meningitis or meningeal carcinomatosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Normal brain parenchyma:</strong> &nbsp;MRI in PRES is usually not normal.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize the clinical and imaging features of PRES, a condition often associated with hypertension and renal dysfunction.</span></span></p>",
      "correct_choice_id": 216285,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54205,
      "choices": [
        {
          "id": 216289,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beading of cerebral arteries</span></span></p>"
        },
        {
          "id": 216290,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aneurysmal dilation of the anterior communicating artery</span></span></p>"
        },
        {
          "id": 216291,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occlusion of the left MCA</span></span></p>"
        },
        {
          "id": 216292,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal cerebral vasculature</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old woman presents with a sudden, severe &quot;thunderclap&quot; headache, different from her usual migraines. She recently started a new weight loss medication. CT head is normal, and LP shows no SAH. What is the MRA most likely to show?</span></span></p>",
      "unique_key": "Q7245889",
      "question_audio": null,
      "question_video": null,
      "map_id": 25699,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) Beading of cerebral arteries</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This presentation suggests reversible cerebral vasoconstriction syndrome (RCVS), often triggered by medications. MRA typically shows the characteristic &quot;beading&quot; pattern of the cerebral arteries.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Aneurysmal dilation of the anterior communicating artery: </strong>Aneurysm would more likely present with SAH. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Occlusion of the left MCA:</strong> MCA occlusion would present with focal neurological deficits. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Normal cerebral vasculature:</strong>&nbsp; Normal vasculature is unlikely in the presence of a vascular headache.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize the presentation of RCVS and the characteristic &quot;beading&quot; pattern on MRA.</span></span></p>",
      "correct_choice_id": 216289,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54206,
      "choices": [
        {
          "id": 216293,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticoagulation with heparin</span></span></p>"
        },
        {
          "id": 216294,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antiplatelet therapy with aspirin</span></span></p>"
        },
        {
          "id": 216295,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate surgical intervention</span></span></p>"
        },
        {
          "id": 216296,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Observation with serial imaging</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman on oral contraceptives presents with worsening headache, nausea, vomiting, and papilledema. MRV reveals thrombosis in the superior sagittal sinus. What is the most appropriate initial management?</span></span></p>",
      "unique_key": "Q4161120",
      "question_audio": null,
      "question_video": null,
      "map_id": 25700,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) Anticoagulation with heparin</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This presentation is consistent with cerebral venous sinus thrombosis (CVST). Anticoagulation with heparin is the initial treatment of choice to prevent clot propagation and promote recanalization.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Antiplatelet therapy with aspirin:</strong> Aspirin is insufficient for CVST. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Immediate surgical intervention:</strong> Surgery is not the initial treatment. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Observation with serial imaging:</strong> Observation without treatment is inappropriate for CVST.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize the presentation of CVST and the importance of immediate anticoagulation for its management.</span></span></p>",
      "correct_choice_id": 216293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54207,
      "choices": [
        {
          "id": 216297,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leigh syndrome </span></span></p>"
        },
        {
          "id": 216298,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MERRF syndrome</span></span></p>"
        },
        {
          "id": 216299,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MELAS syndrome</span></span></p>"
        },
        {
          "id": 216300,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kearns-Sayre syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old boy presents with sudden severe headache, vomiting, and confusion. He has a history of recurrent muscle weakness and pain after exercise, progressive hearing loss, and migraines. Exam shows lethargy, bilateral ptosis, and weakness. Fundoscopy reveals pigmentary retinopathy. Lactate is elevated in blood and CSF. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q9896716",
      "question_audio": null,
      "question_video": null,
      "map_id": 25701,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) MELAS syndrome</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This presentation is classic for MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) syndrome, characterized by the triad of symptoms, muscle weakness, and elevated lactate levels.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Leigh syndrome</strong>: &nbsp;Presents in infancy with developmental regression and respiratory abnormalities. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. MERRF syndrome:</strong> Presents with myoclonus and ragged-red fibers on muscle biopsy. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Kearns-Sayre syndrome: </strong>Presents with ophthalmoplegia, pigmentary retinopathy, and heart block.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective: </u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recognize the classic presentation of MELAS syndrome, a mitochondrial disorder with a multisystemic presentation.</span></span></p>",
      "correct_choice_id": 216299,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}